Insulet (PODD) Current Taxes (2011 - 2012)
Insulet's (PODD) quarterly Current Taxes came in at $4.0 million in Q4 2012, up 1505.26% on a YoY basis from $247000.0 in Q1 2012, and up 1505.26% quarter-over-quarter from $247000.0 in Q4 2011.
Powered by 
Analysis
Insulet (PODD) Current Taxes (2011 - 2012) Analysis & Trends
Insulet (PODD) has reported Current Taxes for 2 consecutive years, with $4.0 million the latest figure, recorded in Q4 2012.
- For the quarter ending Q4 2012, Current Taxes rose 1505.26% year-over-year to $4.0 million; the trailing twelve-month figure through Dec 2012 stood at $4.0 million (up 1505.26% YoY), and the FY2012 full-year result was $4.0 million, up 1505.26% from the prior year.
- Current Taxes grew to $4.0 million in Q4 2012 per PODD's latest filing, from $247000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $4.0 million in Q4 2012 and bottomed at $247000.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 411.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 1.06 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 224.00 Mn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 228.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 86.50 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | - |